First Controlled Study Comparing Cannabis Effects in Teens vs Adults Reveals Surprising Vulnerability and Resilience Patterns

In the first placebo-controlled comparison, adolescents felt less stoned and had fewer memory impairments than adults from the same cannabis dose, but showed impaired impulse control and never felt satisfied, potentially driving escalated use.

Mokrysz, C et al.·Translational psychiatry·2016·Moderate EvidenceRandomized Controlled Trial
RTHC-01227Randomized Controlled TrialModerate Evidence2016RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Moderate Evidence
Sample
N=20

What This Study Found

This groundbreaking study was the first to directly compare cannabis effects in adolescent (16-17) and adult (24-28) male users under controlled conditions.

The results defied simple assumptions about adolescent vulnerability. Compared to adults, adolescents reported feeling less stoned, had fewer psychotomimetic symptoms, less anxiety, and showed less memory impairment from cannabis. Their blood pressure and alertness were also less affected.

But alongside this apparent resilience, two concerning vulnerabilities emerged. First, cannabis impaired response inhibition (impulse control) in adolescents but not adults. Second, adolescents showed no satiety after cannabis: they wanted more regardless of whether they had received active or placebo cannabis, while adults felt satisfied after the active dose.

This combination of reduced subjective effects and lack of satiety could drive adolescents toward escalated use, as they may consume more to achieve the high adults get from less.

Key Numbers

20 adolescents (16-17) vs. 20 adults (24-28), all male cannabis users. Adolescents: less stoned, fewer psychotomimetic symptoms, less memory impairment, less anxiety. BUT: impaired response inhibition, no satiety (wanted more cannabis regardless of active/placebo). Adults: opposite pattern on all measures.

How They Did This

Placebo-controlled, double-blind, crossover design. 20 adolescent males (16-17 years) and 20 adult males (24-28 years), all current cannabis users. Vaporized active or placebo cannabis administered. Assessments: spatial working memory, episodic memory, response inhibition, blood pressure, heart rate, psychotomimetic symptoms, and subjective drug effects.

Why This Research Matters

This is a landmark study. The contrasting profiles of adolescent resilience (blunted subjective and cognitive effects) and vulnerability (impaired inhibition and lack of satiety) provide a mechanistic explanation for why adolescent cannabis use tends to escalate: they feel the effects less, stop themselves less, and never feel they have had enough.

The Bigger Picture

Animal research has long shown different adolescent and adult responses to cannabinoids. This study demonstrates these differences translate to humans and provides a neurobiological framework for understanding adolescent cannabis use patterns: the reduced sensitivity plus impaired inhibition plus absent satiety is a recipe for escalation.

What This Study Doesn't Tell Us

Only male participants. All were current cannabis users, so findings may not apply to naive users. Moderate sample size. Single-session design may not capture effects of regular use. Cannabis was standardized but may not represent typical potency.

Questions This Raises

  • ?Would female adolescents show the same patterns?
  • ?Does the lack of satiety persist with repeated use or develop tolerance?
  • ?Could the impulse control deficit be targeted by interventions to reduce adolescent use escalation?

Trust & Context

Key Stat:
Teens felt less high but never felt satisfied, while adults felt high and satiated
Evidence Grade:
Placebo-controlled crossover design with well-matched age groups. First study of its kind. Limited by male-only sample and moderate size.
Study Age:
Published in 2016. This landmark finding has influenced subsequent research on age-dependent cannabis effects.
Original Title:
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males.
Published In:
Translational psychiatry, 6(11), e961 (2016)
Database ID:
RTHC-01227

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

Do teenagers react differently to cannabis than adults?

Yes, dramatically. This first controlled comparison found teens feel less stoned, have fewer memory problems, and less anxiety from the same cannabis dose. But they also have impaired impulse control and never feel satisfied, potentially driving them to use more.

Why might this lead to escalated use in teens?

The combination of reduced subjective effects (needing more to feel it), impaired inhibition (less ability to stop), and absent satiety (never feeling they have had enough) creates a perfect storm for dose escalation.

Read More on RethinkTHC

Cite This Study

RTHC-01227·https://rethinkthc.com/research/RTHC-01227

APA

Mokrysz, C; Freeman, T P; Korkki, S; Griffiths, K; Curran, H V. (2016). Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males.. Translational psychiatry, 6(11), e961. https://doi.org/10.1038/tp.2016.225

MLA

Mokrysz, C, et al. "Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males.." Translational psychiatry, 2016. https://doi.org/10.1038/tp.2016.225

RethinkTHC

RethinkTHC Research Database. "Are adolescents more vulnerable to the harmful effects of ca..." RTHC-01227. Retrieved from https://rethinkthc.com/research/mokrysz-2016-are-adolescents-more-vulnerable

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.